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In the present s udy, we show for the first time the presence of calcitriol-specific binding sites in hypertonic extracts of cells isolated from human 
fetal small intestine and colon from 13-21 weeks of gestation, Woolf plot analysis of the binding characteristics revealed the presence of a single 
class of high affinity receptors. The presence of specific receptors for calcitriol in fetal intestine and colon opens interesting possibilities as to the 
role of this hormone in human gut development. 
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1. INTRODUCTION 
Besides its well-recognized role in mineral homeo- 
stasis [1,2], calcitriol, the active form of vitamin D, has 
been involved in cellular differentiation and prolifera- 
tion processes [3,4]. Epithelial cells of the small in- 
testine mucosa are in continuous renewal and differen- 
tiation, and are target cells for calcitriol [5]. Between 9 
and 20 weeks of gestation, human gut acquires many of 
the morphological and functional characteristics found 
in adult. During this period, high proliferative activities 
followed by differentiation are recorded in all segments 
of the gut [6-81. To further our understanding of the 
ontogenesis of fetal human gastrointestinal tract, the 
present study was undertaken to verify the presence and 
distribution of calcitriol receptors in the small and large 
intestine of 13-21-week-old fetuses. 
buffer (0.3 M KCl, 10 mM Tris-HCl, 15 mM EDTA) adjusted at pH 
7.4 and containing aprotinin (Trasylol, Boeringher-Mannheim 
Canada, Montreal) as protease inhibitor and dithiotreitol (Sigma 
Chemicals, St. Louis, MI) as antioxidant. Cells were disrupted by 
sonication (4 bursts of 2 s each at an amplitude of 8 ptm) at 4°C and 
centrifuged at 220,~ x g x 30 min. The supemat~ts were 
assayed for the presence of calcitriol receptors by incubating 200~1 of 
cytosol extract in presence of 500 pM la,25dihydroxy[26,27_meth- 
yl-‘Hlcholecalciferol ([3H]calcitriol, 176 Ci/mmol; Amersham, 
Oakville, Canada) with and without a lOO-fold excess of unlabeled 
hormone (kind gift of Dr Milan Uskokovic, Hoffman-Laroche, 
Nutley, NJ). The steroid-receptor complex was adsorbed on hydrox- 
yapatite (lo]. In some samples, saturation analysis of the receptors 
was performed in presence of increasing concentrations of tritiated 
calcitriol (40-500 PM). Dissociation constants (Kd) and maximum 
binding capacity (B,,& were estimated by the Woolf plot analysis 
[ 111. An aliquot of each hypertonic supernatant was kept for the 
measurement of DNA [12]. 
3. RESULTS 
2. MATERIALS AND METHODS 
3.1, Comparative development pattern of calcitriol 
2.1. Tissue specimens and cell preparation 
Smail intestine and/or colon from 17 fetuses ranging from 13 to 21 
weeks were obtained after legal abortion. Epithelial cells were ob- 
tained by manual shaking of everted segments of small intestine or 
colon in a 1.5 mM EDTA/0.25 M NaCl solution at 4°C as already 
described [8,9]. Cells were centrifuged at 500 x g x 5 min and 
frozen at - 80°C until used. 
binding 
2.2. Binding measurement 
Frozen cells were thawed and resuspended in l-2 ml of hypertonic 
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Specific binding pattern of calcitriol to the hyper- 
tonic extracts of epithelial cells is shown in table 1. All 
proximal small intestine samples tested, as early as 13 
weeks of gestation, exhibited calcitriol binding activity. 
No particular developmental pattern could be elicited 
with the samples collected. In several fetuses, specific 
binding was measured in all intestinal segments in- 
cluding the colon. The specific binding had a tendency 
to be lower in the distal portion of small intestine and 
in the proximal and distal parts of colon. 
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Table 1 Table 2 
Distribution of calcitriol-specific binding in individual fetal small in- 
testine and colon specimens 
Binding characteristics of proximal small intestine calcitriol 
receptors* 
Weeks Small intestine Colon 
gestation 
Proximal Median Distal Proximal Distal 
13 0.336 
16 0.048 
16 0.150 
17 0.117 
17 0.084 0.091 0.077 
17 0.111 0.090 0.078 
17 0.099 
18 0.462 0.494 0.356 
19 0.227 
19 0.031 0.033 n.d. 0.017 
19 0.080 0.069 0007 0.088 
19 0.034 0.034 n-d. 
19 0.067 0.055 0.040 
19 0.458 
20 0.377 
21 0.331 0.097 0088 0.096 0.053 
21 0.380 0.389 0.270 
Specific binding was measured as described in section 2 in the 
presence of 50 pM [3H]calcitriol with or without lOO-fold concentra- 
tion of unlabeled hormone. Results are expressed as fmol calcitriol 
bound per fig DNA. n.d. = not detectable 
3.2. Characteristics of calcitriol binding 
Woolf plot of bound [‘H]calcitriol displacement by 
increasing concentration of radioinert hormone were 
performed on hypertonic extracts of epithelial cells of 
the proximal small intestine. An example is given in 
fig. I. A single class of high affinity binding sites was ex- 
hibited. The individual dissociation constants (&) and 
maximal binding (&,& are listed in table 2. Values were 
of the. same order of magnitude whether they were 
derived from samples obtained at 18 or 21 weeks of 
gestation. They range from 189 to 323 pM and from 
0.571 to 0.770 fmol/pg DNA, respectively. 
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Fig. 1. Woolf plot of calcitriol-specific binding by hypertonic ytosolic 
extracts of cells isolated from proximal small intestine. The extracts, 
prepared as described in section 2, were incubated for 16 h at 4°C with 
increasing concentrations of [sH]calcitriol in the presence of a 
IOO-fold molar excess of radioinert hormone. Bound sterol-receptor 
complex was adsorbed on hydroxyapatite. The line fits a simple linear 
regression (r= 0.99). 
Weeks gestation & (PM) Bmax (fmol/pg DNA) 
18 189 f 41 0.620 f 0.13 
19 323 f 17 0.770 + 0.05 
20 252 f 57 0.571 f 0.13 
21 26.5 f 26 0.603 * 0.06 
*The& and Bmax values were calculated from the Woolf plot analysis 
[9]. The values are the mean f SE (x = 3) 
4. DISCUSSION 
We have established the presence of specific receptors 
for calcitriol in epithelial cells from both intestine and 
colon of human fetuses. Data concerning such recep- 
tors in human gut is scarce and in fact, nonexistent for 
fetal tissues. The observed binding affinities and 
capacities for calcitriol in the epithelial cells from the 
proximal small intestine are similar to those reported 
for human adult jejunum [14] illustrating that the in- 
testinal cells acquire this function very early during 
development. The binding affinities reported here are, 
however, slightly lower than those reported earlier for 
human cultured amniocytes [13]. The presence of 
specific calcitriol binding sites in the normal fetal colon 
is particularly interesting since such sites were also 
found to be present in the human colonic cell line 
HT-29 1151. However, our data differ markedly from 
those published for developing rodents. Indeed in both 
rat [ 161 and rabbit [ 171, the ontogeny of calcitriol recep- 
tors is initiated only during postnatal development. 
Therefore this report warrants caution in extrapolating, 
to human, data observed in rodents. The physiological 
role of these receptors is not fully understood. The 
vitamin D-dependent CaBP are best known molecular 
markers of vitamin D action in target cells. Recently, 
9K-CaBP gene expression was elicited as early as 14 
weeks of gestation in human duodenum with no signifi- 
cant change in 9K-CaBP mRNA levels from 14 to 32 
weeks of gestation [lS]. In rodents, sucrase, a marker 
enzyme for intestinal cell maturation, is elicited at the 
time of weaning [19]. The onset of this activity is con- 
comitant to the appearance of calcitriol receptors [16]. 
Interestingly sucrase appears early in human fetal 
development when calcitriol receptors, as we show in 
this report, are also present. 
Based on these obse~ations and on the fact that 
calcitriol can promote cell differentiation, the presence 
of specific receptors in human fetal small intestine and 
colon opens interesting possibilities as to the role of 
calcitriol in human gut development and in the on- 
togeny of digestive enzymes. 
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